Approved cancer drug may reduce kidney damage linked to nail-patella syndrome

An approved cancer drug may reduce kidney damage linked to nail-patella syndrome, according to a study led by Dr. Ralph Witzgall.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.